Filter
Showing 16–30 of 44 results
Participants will develop the capability to manage end-to-end vaccine tender processes under UIP, ensure regulatory and documentation compliance, optimize bid strategies, mitigate procurement risks, and maintain supply continuity aligned with public health obligations.
Participants will develop the capability to manage end-to-end public procurement processes in the pharmaceutical sector with confidence and compliance. They will understand tender lifecycle management, regulatory alignment, risk mitigation, ethical safeguards, and contract governance—enabling them to execute procurement activities with transparency, accountability, and strategic effectiveness.
Participants will be able to navigate the AI tool ecosystem, confidently use leading AI platforms, design integrated AI-driven workflows, evaluate return on investment and implementation feasibility, deploy AI solutions across teams with structured governance, apply security and compliance best practices, and measure tangible business impact in terms of productivity, quality, and cost efficiency.
Participants will be able to understand the fundamentals of AI and large language models, craft structured and high-impact prompts, apply advanced techniques such as chain-of-thought and persona-based prompting, integrate AI tools into business workflows for improved output quality, recognize AI limitations and apply human judgment appropriately, and implement ethical and secure AI practices within their organizations.
Participants will gain the ability to plan and manage pharmaceutical supply chains, optimize procurement and inventory, ensure regulatory compliance, manage logistics and cold chain systems, and implement risk mitigation strategies to improve efficiency and product availability.
Participants will be able to develop trust-based engagement strategies with healthcare professionals, apply consultative selling techniques, leverage data-driven customer insights, align promotional activities with compliance standards, and execute targeted marketing initiatives to drive sustainable sales performance.
Participants will be able to manage end-to-end pharmacovigilance workflows efficiently, ensure high data quality standards, monitor compliance metrics and SLAs, optimize operational performance, and support audit and regulatory inspection readiness.
Participants will be able to build competitive intelligence frameworks, analyze competitor pipelines and patents, interpret regulatory and clinical trial trends, assess market entry risks, and integrate CI insights into product development and lifecycle strategy decisions.
Participants will be able to identify critical quality attributes (CQA), define critical process parameters (CPP), apply risk assessment and design of experiments (DoE), establish design space, and implement control strategies to ensure optimized and scalable pharmaceutical processes.
Participants will be able to apply ICH-based Quality Risk Management principles, conduct risk assessments using structured tools, integrate risk controls into quality systems, document risk decisions, and maintain a proactive risk-based compliance culture.
Participants will be able to develop qualification protocols, execute IQ, OQ, and PQ activities for laboratory equipment, apply risk-based approaches, ensure proper documentation, and maintain a validated state throughout the equipment lifecycle.
Participants will be able to implement the three-stage process validation lifecycle, define critical process parameters, design validation protocols, analyze process data statistically, and maintain continued process verification aligned with regulatory expectations.
Participants will be able to design and manage a robust pharmaceutical QMS, integrate risk-based decision-making, strengthen deviation and CAPA processes, ensure documentation control, and maintain inspection readiness aligned with global regulatory standards.
Participants will be able to apply SPC tools, construct and interpret control charts, evaluate process capability indices, detect process trends, and integrate statistical monitoring into pharmaceutical quality and validation systems.
Participants will be able to apply GDP principles, implement ALCOA+ requirements, write structured and compliant technical documents, prevent documentation errors, and maintain inspection-ready records in accordance with global pharmaceutical regulations.